Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AGE | AgeX Therapeutics, Inc.

Index- P/E- EPS (ttm)-0.29 Insider Own0.10% Shs Outstand37.95M Perf Week-4.75%
Market Cap28.48M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float21.45M Perf Month3.08%
Income-11.10M PEG- EPS next Q- Inst Own12.70% Short Float / Ratio0.37% / 3.10 Perf Quarter10.66%
Sales0.04M P/S791.17 EPS this Y-21.80% Inst Trans-0.70% Short Interest0.08M Perf Half Y17.58%
Book/sh-0.58 P/B- EPS next Y- ROA-147.50% Target Price- Perf Year25.42%
Cash/sh0.01 P/C94.94 EPS next 5Y- ROE59.60% 52W Range0.37 - 1.00 Perf YTD36.35%
Dividend- P/FCF- EPS past 5Y-8.50% ROI- 52W High-24.75% Beta1.67
Dividend %- Quick Ratio0.10 Sales past 5Y- Gross Margin- 52W Low102.28% ATR0.07
Employees5 Current Ratio0.10 Sales Q/Q-25.00% Oper. Margin- RSI (14)50.01 Volatility7.06% 11.04%
OptionableNo Debt/Eq- EPS Q/Q-1.90% Profit Margin- Rel Volume1.19 Prev Close0.76
ShortableYes LT Debt/Eq- EarningsAug 14 AMC Payout- Avg Volume25.71K Price0.75
Recom- SMA200.54% SMA500.15% SMA20014.07% Volume30,577 Change-0.99%
Aug-30-23 07:00AM
Aug-14-23 04:05PM
Jul-24-23 06:28PM
Jul-21-23 05:32PM
May-23-23 04:05PM
04:05PM Loading…
May-12-23 04:05PM
Apr-26-23 04:05PM
Mar-31-23 04:05PM
Nov-25-22 03:41PM
Nov-10-22 04:05PM
Aug-12-22 04:05PM
May-18-22 08:30AM
May-13-22 04:05PM
Mar-29-22 04:05PM
Dec-14-21 08:30AM
08:30AM Loading…
Nov-30-21 08:30AM
Nov-23-21 04:05PM
Nov-12-21 04:05PM
Aug-13-21 04:05PM
Jul-23-21 04:15PM
May-17-21 04:05PM
Mar-31-21 04:05PM
Mar-12-21 08:00AM
Mar-10-21 08:00AM
Mar-02-21 08:00AM
Feb-02-21 11:24PM
Dec-22-20 03:08PM
Nov-27-20 04:13PM
Nov-16-20 04:05PM
Oct-28-20 08:00AM
07:59AM Loading…
Sep-15-20 07:59AM
Sep-09-20 08:00AM
Aug-14-20 04:05PM
Aug-07-20 07:02AM
Jun-16-20 08:00AM
Jun-05-20 04:15PM
Jun-02-20 08:00AM
May-29-20 08:00AM
May-21-20 08:30AM
May-14-20 04:05PM
May-01-20 08:54AM
Mar-30-20 05:40PM
Mar-20-20 09:00AM
Feb-28-20 08:00AM
Feb-09-20 09:12AM
Feb-03-20 08:00AM
Jan-29-20 08:00AM
Jan-14-20 08:00AM
Dec-26-19 08:00AM
Dec-10-19 08:00AM
Dec-09-19 07:00AM
Nov-14-19 04:00PM
Nov-13-19 09:50AM
Nov-11-19 05:28AM
Nov-08-19 06:58PM
Oct-30-19 08:00AM
Oct-11-19 08:00AM
Sep-10-19 08:00AM
Sep-09-19 07:00AM
Sep-04-19 08:00AM
Aug-14-19 05:16PM
Aug-05-19 05:14PM
Jul-09-19 08:00AM
May-15-19 04:05PM
May-01-19 08:00AM
Apr-05-19 08:00AM
Apr-01-19 04:48PM
Mar-22-19 07:00AM
Mar-21-19 07:00AM
Mar-07-19 07:00AM
Feb-14-19 08:00AM
Jan-31-19 08:00AM
Jan-22-19 08:00AM
Jan-10-19 08:00AM
Jan-09-19 08:00AM
Jan-04-19 08:00AM
Jan-02-19 07:00AM
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEST MICHAEL DChief Executive OfficerMar 11Option Exercise0.003,125043,042Mar 14 09:32 PM
WEST MICHAEL DChief Executive OfficerDec 11Option Exercise0.003,125040,998Dec 13 09:22 PM